336 related articles for article (PubMed ID: 29709981)
21. Activity of ceftazidime-avibactam against multidrug-resistance Enterobacteriaceae expressing combined mechanisms of resistance.
López-Hernández I; Alonso N; Fernández-Martínez M; Zamorano L; Rivera A; Oliver A; Conejo MC; Martínez-Martínez L; Navarro F; Pascual A
Enferm Infecc Microbiol Clin; 2017 Oct; 35(8):499-504. PubMed ID: 27887765
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of MicroScan WalkAway and Vitek 2 for determination of the susceptibility of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates to cefepime, cefotaxime and ceftazidime.
Jang W; Park YJ; Park KG; Yu J
J Antimicrob Chemother; 2013 Oct; 68(10):2282-5. PubMed ID: 23671215
[TBL] [Abstract][Full Text] [Related]
23. Impact of CLSI and EUCAST Cefepime breakpoint changes on the susceptibility reporting for Enterobacteriaceae.
Bork JT; Heil EL; Leekha S; Fowler RC; Hanson ND; Majumdar A; Johnson JK
Diagn Microbiol Infect Dis; 2017 Dec; 89(4):328-333. PubMed ID: 29031525
[TBL] [Abstract][Full Text] [Related]
24. Characterization of ESBL- and AmpC-Producing Enterobacteriaceae from Diseased Companion Animals in Europe.
Bogaerts P; Huang TD; Bouchahrouf W; Bauraing C; Berhin C; El Garch F; Glupczynski Y;
Microb Drug Resist; 2015 Dec; 21(6):643-50. PubMed ID: 26098354
[TBL] [Abstract][Full Text] [Related]
25. [Carbapenem resistance in ESBL positive Enterobacteriaceae isolates causing invasive infections].
Eser OK; Altun Uludağ H; Ergin A; Boral B; Sener B; Hasçelik G
Mikrobiyol Bul; 2014 Jan; 48(1):59-69. PubMed ID: 24506716
[TBL] [Abstract][Full Text] [Related]
26. Molecular characterization of extended-spectrum beta-lactamases and its correlation with clinical laboratory standards institute interpretive criteria for disk diffusion susceptibility testing in enterobacteriaceae isolates in Thaialnd.
Tangkoskul T; Tiengrim S; Onsomang S; Pati N; Aswapokee N; Thamlikitkul V; Chayakulkeeree M
Southeast Asian J Trop Med Public Health; 2012 Nov; 43(6):1461-9. PubMed ID: 23413710
[TBL] [Abstract][Full Text] [Related]
27. High prevalence of multidrug resistant ESBL- and plasmid mediated AmpC-producing clinical isolates of Escherichia coli at Maputo Central Hospital, Mozambique.
Estaleva CEL; Zimba TF; Sekyere JO; Govinden U; Chenia HY; Simonsen GS; Haldorsen B; Essack SY; Sundsfjord A
BMC Infect Dis; 2021 Jan; 21(1):16. PubMed ID: 33407206
[TBL] [Abstract][Full Text] [Related]
28. Multi-centre evaluation of a phenotypic extended spectrum β-lactamase detection guideline in the routine setting.
Platteel TN; Cohen Stuart JW; de Neeling AJ; Voets GM; Scharringa J; van de Sande N; Fluit AC; Bonten MJM; Leverstein-van Hall MA;
Clin Microbiol Infect; 2013 Jan; 19(1):70-76. PubMed ID: 22268620
[TBL] [Abstract][Full Text] [Related]
29. Extended spectrum AmpC and metallo-beta-lactamases in Serratia and Citrobacter spp. in a disc approximation assay.
Rizvi M; Fatima N; Rashid M; Shukla I; Malik A; Usman A; Siddiqui S
J Infect Dev Ctries; 2009 May; 3(4):285-94. PubMed ID: 19759492
[TBL] [Abstract][Full Text] [Related]
30. Extended spectrum AmpC and metallo-beta-lactamases in Serratia and Citrobacter spp. in a disc approximation assay.
Rizvi M; Fatima N; Rashid M; Shukla I; Malik A; Usman A; Siddiqui S
J Infect Dev Ctries; 2009 Apr; 3(3):177-86. PubMed ID: 19759472
[TBL] [Abstract][Full Text] [Related]
31. Characterization of clinical isolates of Enterobacteriaceae from Italy by the BD Phoenix extended-spectrum beta-lactamase detection method.
Sanguinetti M; Posteraro B; Spanu T; Ciccaglione D; Romano L; Fiori B; Nicoletti G; Zanetti S; Fadda G
J Clin Microbiol; 2003 Apr; 41(4):1463-8. PubMed ID: 12682131
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of ESBL/AmpC genes and specific clones among the third-generation cephalosporin-resistant Enterobacteriaceae from canine and feline clinical specimens in Japan.
Maeyama Y; Taniguchi Y; Hayashi W; Ohsaki Y; Osaka S; Koide S; Tamai K; Nagano Y; Arakawa Y; Nagano N
Vet Microbiol; 2018 Mar; 216():183-189. PubMed ID: 29519514
[TBL] [Abstract][Full Text] [Related]
33. Characteristics of extended-spectrum β-lactamase (ESBL)- and pAmpC beta-lactamase-producing Enterobacteriaceae of water samples in Tunisia.
Ben Said L; Jouini A; Alonso CA; Klibi N; Dziri R; Boudabous A; Ben Slama K; Torres C
Sci Total Environ; 2016 Apr; 550():1103-1109. PubMed ID: 26871556
[TBL] [Abstract][Full Text] [Related]
34. Modified CLSI extended-spectrum β-lactamase (ESBL) confirmatory test for phenotypic detection of ESBLs among Enterobacteriaceae producing various β-lactamases.
Poulou A; Grivakou E; Vrioni G; Koumaki V; Pittaras T; Pournaras S; Tsakris A
J Clin Microbiol; 2014 May; 52(5):1483-9. PubMed ID: 24574283
[TBL] [Abstract][Full Text] [Related]
35. High prevalence of CTX-M-15 and first report of CTX-M-3, CTX-M-22, CTX-M-28 and plasmid-mediated AmpC beta-lactamase producing Enterobacteriaceae causing urinary tract infections in Bosnia and Herzegovina in hospital and community settings.
Ibrahimagić A; Bedenić B; Kamberović F; Uzunović S
J Infect Chemother; 2015 May; 21(5):363-9. PubMed ID: 25638292
[TBL] [Abstract][Full Text] [Related]
36. In Vivo Evolution of CMY-2 to CMY-33 β-Lactamase in Escherichia coli Sequence Type 131: Characterization of an Acquired Extended-Spectrum AmpC Conferring Resistance to Cefepime.
Pires J; Taracila M; Bethel CR; Doi Y; Kasraian S; Tinguely R; Sendi P; Bonomo RA; Endimiani A
Antimicrob Agents Chemother; 2015 Dec; 59(12):7483-8. PubMed ID: 26392491
[TBL] [Abstract][Full Text] [Related]
37. [Detection of bla(CTX-M) beta-lactamase genes in extended-spectrum beta-lactamase producing gram-negative bacteria].
Bayraktar B; Toksoy B; Bulut E
Mikrobiyol Bul; 2010 Apr; 44(2):187-96. PubMed ID: 20549952
[TBL] [Abstract][Full Text] [Related]
38. Effect of the Different Plasmid-Mediated AmpC Beta-Lactamase Genotypes on the Phenotypic Detection of ESBL in Enterobacteriaceae Isolates.
Adel H; Elewa A; Mashaly M
Clin Lab; 2022 Dec; 68(12):. PubMed ID: 36546742
[TBL] [Abstract][Full Text] [Related]
39. Characterization of plasmid-mediated β-lactamases in fecal colonizing patients in the hospital and community setting in Spain.
Garrido A; Seral C; Gude MJ; Casado C; González-Domínguez M; Sáenz Y; Castillo FJ
Microb Drug Resist; 2014 Aug; 20(4):301-4. PubMed ID: 24328895
[TBL] [Abstract][Full Text] [Related]
40. Consequences of revised CLSI and EUCAST guidelines for antibiotic susceptibility patterns of ESBL- and AmpC β-lactamase-producing clinical Enterobacteriaceae isolates.
Hombach M; Mouttet B; Bloemberg GV
J Antimicrob Chemother; 2013 Sep; 68(9):2092-8. PubMed ID: 23633681
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
